As Senior Vice President of Digital & Innovation, Michael drives two main areas of work: early research and incubation on emerging trends and technologies that may impact the use of USP standards and the industries in which USP works; and the creation of digital products and solutions to help stakeholders make better use of USP standards or derive valuable insights to assess the resilience of medicine supply chains and ensure the quality of medicines.
Michael joined USP in 2016 as Vice President to lead the creation of USP’s Quality Institute. In 2017, his role expanded to include USP’s Research & Innovation efforts. He has been a member of USP’s executive team and Senior Vice President of Digital & Innovation since 2020. In 2025, further consolidation of USP’s digital offerings under Michael’s leadership occurred to accelerate the development of digital solutions that enable stakeholders to more seamlessly integrate USP standards into their increasingly automated and digital workflows.
Before joining USP, Michael held various leadership roles, including Deputy Vice President at PhRMA, Associate Principal at McKinsey & Company, and bioinformatician with the team that sequenced Human Chromosome XIV as part of the Human Genome Project.
Career Highlights:
- PhRMA: Deputy Vice President, Science and Regulatory Advocacy
- McKinsey & Company: Associate Principal, Pharmaceutical and Medical Products practice
- Genomining: Lead bioinformatics developer
- Genoscope, the French National Genome Center: Bioinformatician, Human Genome Project
Education:
- Cornell Johnson Graduate School of Management, M.B.A.
- Concordia University, B.S. and M.Sc., Biology
Professional Achievements:
- Defining, establishing, and initially leading the USP Quality Institute
- Influencing the content of the PDUFA V Goals Letter and the 21st Century Cures Act by leading the definition of the Pharmaceutical Industry advocacy position on the use of Real World Evidence in Regulatory decision making
- Participating in the Human Genome Project by automating the genomic sequence assembly, quality assessment, and lab operations of Human Chromosome XIV
